Conversation with The Cancer LetterCOVID-19 & CancerFree Ruben Mesa: Facing a dramatic COVID-19 spike in San Antonio July 10, 2020Vol.46 No.28By Paul Goldberg
Clinical RoundupFree NCCN Guidelines for patients can help patients recognize side-effects of immunotherapy July 02, 2020Vol.46 No.27
COVID-19 & CancerFreeTrials & Tribulations (Social + geographic) distance = Ongoing challenges in disparities for rural cancer patients July 02, 2020Vol.46 No.27By Jennifer Dill, Marsha Kutter and Peggy Wisher
Conversation with The Cancer LetterCOVID-19 & CancerFree Northwell Health reopens cancer services after COVID-19 delugeNew York health system explores NCI designation in affiliation with Cold Spring Harbor Laboratory July 02, 2020Vol.46 No.27By Paul Goldberg
Drugs & TargetsFree FDA approves Keytruda for cutaneous squamous cell carcinoma June 26, 2020Vol.46 No.26
Drugs & TargetsFree Selinexor receives FDA approval for relapsed/refractory diffuse large B-cell lymphoma June 26, 2020Vol.46 No.26
Drugs & TargetsFree Keytruda approved in China for second-line treatment of locally advanced or metastatic ESCC indication June 26, 2020Vol.46 No.26
Clinical RoundupFree FDA pilot program to communicate patient reported outcomes from cancer clinical trials June 26, 2020Vol.46 No.26
